SUBCHRONIC ORAL TOXICITY STUDY IN WISTAR RATS OF SHILAJITWADI VATI, A HERBOMETALLIC FORMULATION

Shilajitwadi vati, a traditional herbometallic formulation, is used for treating various ailments. This subchronic toxicity study evaluated its safety during extended oral administration due to the inclusion of heavy metals. In compliance with OECD guideline 408, animals were divided into four groups: three received Shilajitwadi vati at doses of 51.36, 205.44, and 513.6 mg kg-1 for 90 days, while the control group received only the vehicle. All the animals showed no signs of toxicity or mortality throughout the study, with steady weight gain and increased feed and water intake. Urine samples, haematological and biochemical parameters were analyzed on day 91, revealing no significant differences between treated and control groups. All data were analysed by one way ANOVA using GraphPad Prism. Histopathological examination showed no adverse effects on vital organs and no metal accumulation in tissues supporting the safety of Shilajitwadi vati. These findings suggest that Shilajitwadi vati is a safe therapeutic option for prolonged use.

Authors

Publication Details

Journal
INDIAN DRUGS
Published
2025-03-28
DOI
https://doi.org/10.53879/id.62.03.15138
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUBCHRONIC ORAL TOXICITY STUDY IN WISTAR RATS OF SHILAJITWADI VATI, A HERBOMETALLIC FORMULATION

Shubhangi H. Pawar, Shishir Pande, Abhay N. Kulkarni, Rajshree A. Kulkarni et al.
INDIAN DRUGS
Drug-Induced Hepatotoxicity and Protection
article

SUBCHRONIC ORAL TOXICITY STUDY IN WISTAR RATS OF SHILAJITWADI VATI, A HERBOMETALLIC FORMULATION

Shubhangi H. Pawar, Shishir Pande, Abhay N. Kulkarni, Rajshree A. Kulkarni, M. Mahalaxmi, Utkarsha R. Ohol
article en

Abstract

Shilajitwadi vati, a traditional herbometallic formulation, is used for treating various ailments. This subchronic toxicity study evaluated its safety during extended oral administration due to the inclusion of heavy metals. In compliance with OECD guideline 408, animals were divided into four groups: three received Shilajitwadi vati at doses of 51.36, 205.44, and 513.6 mg kg-1 for 90 days, while the control group received only the vehicle. All the animals showed no signs of toxicity or mortality throughout the study, with steady weight gain and increased feed and water intake. Urine samples, haematological and biochemical parameters were analyzed on day 91, revealing no significant differences between treated and control groups. All data were analysed by one way ANOVA using GraphPad Prism. Histopathological examination showed no adverse effects on vital organs and no metal accumulation in tissues supporting the safety of Shilajitwadi vati. These findings suggest that Shilajitwadi vati is a safe therapeutic option for prolonged use.

INDIAN DRUGSVol. 62(03)
Openalex Percentile: Top 91%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SUBCHRONIC ORAL TOXICITY STUDY IN WISTAR RATS OF SHILAJITWADI VATI, A HERBOMETALLIC FORMULATION — Shubhangi H. Pawar, Shishir Pande, et al. · INDIAN DRUGS (2025) | TGRS Research Map | TGRS